Search

everythinglearnresearchcommunity

for

Search:↓

Altering maternal cortisol during pregnancy can improve wool growth in Merino sheep.

Dkk4 is necessary for the initial development and arrangement of hair follicles.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Marine microbes could be used in cosmetics for sun protection, skin care, and possibly preventing hair loss.

The method increases stem-like cells for better skin regeneration.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Ruxolitinib can cause a delayed skin reaction on the nose.

Ruxolitinib can help regrow hair in severe alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Topical JAK inhibitors may help treat some skin conditions but need more research.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.